Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Goodwill: 2012-2025

Historic Goodwill for Ascendis Pharma A (ASND) over the last 11 years, with Sep 2025 value amounting to $4.4 million.

  • Ascendis Pharma A's Goodwill fell 2.99% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 2.99%. This contributed to the annual value of $4.4 million for FY2024, which is 8.31% down from last year.
  • Per Ascendis Pharma A's latest filing, its Goodwill stood at $4.4 million for Q3 2025, which was up 1.97% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, Ascendis Pharma A's Goodwill ranged from a high of $6.8 million in Q1 2021 and a low of $4.1 million during Q1 2025.
  • Over the past 3 years, Ascendis Pharma A's median Goodwill value was $4.5 million (recorded in 2024), while the average stood at $4.6 million.
  • As far as peak fluctuations go, Ascendis Pharma A's Goodwill soared by 75.26% in 2021, and later declined by 21.57% in 2022.
  • Ascendis Pharma A's Goodwill (Quarterly) stood at $6.0 million in 2021, then dropped by 18.33% to $4.9 million in 2022, then fell by 3.48% to $4.8 million in 2023, then declined by 9.47% to $4.3 million in 2024, then fell by 2.99% to $4.4 million in 2025.
  • Its Goodwill was $4.4 million in Q3 2025, compared to $4.3 million in Q2 2025 and $4.1 million in Q1 2025.